Adult Hodgkin’s Lymphoma in Indonesian National Cancer Center Hospital: An Observational Study
Abstract
Background: Hodgkin’s lymphoma (HL) is a malignancy of lymphatic glands whose incidence is higher in Asia than in other continents and it is highly curable amongst other hematological malignancies. Our study aims to establish distribution data among HL patients in the Indonesian National Cancer Hospital.
Method: A cohort retrospective was conducted from 2017 to 2021 on HL patients. Data on demographic and clinical characteristics were collected and described.
Result: From 177 HL subjects, 52.5% were men with a median age of 32 years. B-symptoms occurred in 30.1% of subjects. Most subjects have great performance status (44%) and normal body mass index (39.6%). Comorbidities found were diabetes mellitus (10.3%) and hypertension (8.1%). By hematological examination, lactate dehydrogenase (LDH) level was found 85.7% more than 240 U/dL, hemoglobin (Hb) level 71.6% non-anemic, leukocytosis in 33.5%, and thrombocytosis in 59.4%. The disease stage is mostly in stage 2 (51%), with 19.2% having extra nodal lesions which are commonly found in bone marrow (32.2%). The outcome showed that 69.2% of subjects survived.
Conclusion: In general, the majority of subjects were young adult males, with no B-symptoms, great performance status, no comorbidity, elevated LDH levels, normal Hb and white blood cell counts, high platelet counts, and were diagnosed with stage 2 disease. Most patients with Hodgkin’s Lymphoma survived for 5 years.
Keywords
DOI: 10.33371/ijoc.v18i4.1273
Article Metrics
Abstract View: 691, 
PDF Download: 246
References
International Agency for Research on Cancer. Global Cancer Observatory Indonesia Fact Sheet 2022 [Internet]. [cited 2024 Feb 23]. Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/360-indonesia-fact-sheet.pdf
Moccia AA, Donaldson J, Chhanabhai M, Hoskins PJ, Klasa RJ, Savage KJ, et al. International Prognostic Score in Advanced-Stage Hodgkin’s Lymphoma: Altered Utility in the Modern Era. J Clin Oncol. 2012 Sep 20;30(27):3383–8.
Cojbasic I, Macukanovic-Golubovic L. Analysis of Prognostic Factors In Hodgkin ’ S Lymphoma with Regard to Response to Treatment. Facta Universitatis. 2007;14(3):117-20.
Kaseb H, Babiker HM. Hodgkin Lymphoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Nov 23]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK499969/
Cancer Research UK. Hodgkin lymphoma incidence statistics [Internet]. 2015 [cited 2024 Feb 23]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/hodgkin-lymphoma/incidence
Qi J, Gu C, Wang W, Xiang M, Chen X, Fu J. Elevated Lactate Dehydrogenase Levels Display a Poor Prognostic Factor for Non-Hodgkin’s Lymphoma in Intensive Care Unit: An Analysis of the MIMIC-III Database Combined With External Validation. Front Oncol. 2021 Oct 28;11:753712.
Cancer Research UK. Survival [Internet]. [cited 2024 Feb 28]. Available from: https://www.cancerresearchuk.org/about-cancer/hodgkin-lymphoma/survival
Meng J, Chang C, Pan H, Zhu F, Xiao Y, Liu T, et al. Epidemiologic characteristics of malignant lymphoma in Hubei, China. Medicine (Baltimore). 2018 Aug 21;97(35):e12120.
Huang J, Pang WS, Lok V, Zhang L, Lucero-Prisno DE, Xu W, et al. Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis. J Hematol OncolJ Hematol Oncol. 2022 Dec;15(1):1–11.
Basudan AM, Althani M, Abudawood M, Farzan R, Alshuweishi Y, Alfhili MA. A Comprehensive Two-Decade Analysis of Lymphoma Incidence Patterns in Saudi Arabia. J Clin Med. 2024 Jan;13(6):1652.
Anggorowati N, Indrawati, Dhyanti AL, Arkananda H, Rizki SH, Setiawan SA, et al. Sociodemographic and Clinicopathological Features of Lymphoma Patients in Indonesia: A report from Special Region of Yogyakarta Province. Asian Pac J Environ Cancer. 2021;4(1):33–8.
Roemer K, Pfreundschuh M. How do estrogens control lymphoma? Blood. 2014 Mar 27;123(13):1980–1.
Boo YL, Ting HSY, Yap DFS, Toh SG, Lim SM. Clinical features and treatment outcomes of Hodgkin lymphoma: A retrospective review in a Malaysian tertiary hospital. Blood Res. 2019 Sep 30;54(3):210–7.
Strongman H, Brown A, Smeeth L, Bhaskaran K. Body mass index and Hodgkin’s lymphoma: UK population-based cohort study of 5.8 million individuals. Br J Cancer. 2019 Apr;120(7):768–70.
Karakas. IDF Western Pacific Members [Internet]. International Diabetes Federation. [cited 2020 Mar 4]. Available from: https://idf.org/our-network/regions-members/western-pacific/members/104-indonesia.html
Mashuri YA, Ng N, Santosa A. Socioeconomic disparities in the burden of hypertension among Indonesian adults - a multilevel analysis. Glob Health Action. 15(1):2129131.
Çokgezer S, Elverdi T, Salihoğlu A, Ar MC, Öngören Ş, Başlar Z, et al. Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades. Cancer Manag Res. 2022 Jun 7;14:1911–21.
van Spronsen DJ, Janssen-Heijnen ML, Breed WP, Coebergh JW. Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin’s disease and non-Hodgkin’s lymphoma, 1993-1996. Ann Hematol. 1999 Jul;78(7):315–9.
National Comprehensive Cancer Network. Hodgkin Lymphoma [Internet]. [cited 2024 Aug 14]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/hodgkins.pdf
Bierman PJ, Lynch JC, Bociek RG, Whalen VL, Kessinger A, Vose JM, et al. The International Prognostic Factors Project score for advanced Hodgkin’s disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation. Ann Oncol. 2002 Sep 1;13(9):1370–7.
Hohaus S, Massini G, Giachelia M, Vannata B, Bozzoli V, Cuccaro A, et al. Anemia in Hodgkin’s Lymphoma: The Role of Interleukin-6 and Hepcidin. J Clin Oncol. 2010 May 20;28(15):2538–43.
Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE, Inwards DJ, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma. Haematologica. 2012 Feb;97(2):262.
Akdeniz A, Mehtap Ö, Karakuş V, Ünal S, Aygün K, Temel GÖ, et al. Are Platelet-related Parameters Predictive of the Prognosis of Hodgkin’s Lymphoma?
Ruan GJ, Gandhi S, Abeykoon JP, Schram S, Habermann TM, Sandefur BJ, et al. Elevated Serum Lactate in Patients With Lymphoma: It Is Not Always Infection. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr 1;5(2):423–30.
Huang J, Pang WS, Lok V, Zhang L, Lucero-Prisno DE, Xu W, et al. Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis. J Hematol OncolJ Hematol Oncol. 2022 May 11;15:57.
International Agency for Research on Cancer. 360-indonesia-fact-sheet.pdf [Internet]. [cited 2024 Jul 5]. Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/360-indonesia-fact-sheet.pdf
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Email this article 
